Literature DB >> 27874979

Risk factors for recurrence of hypertensive disorders of pregnancy, a population-based cohort study.

Cathrine Ebbing1, Svein Rasmussen2, Rolv Skjaerven3,4, Lorentz M Irgens3,4.   

Abstract

INTRODUCTION: Hypertensive disorders of pregnancy (HDP) tend to recur from one pregnancy to the next. The aims of the study were to assess the recurrence risk according to type of HDP defined by gestational age at birth and to examine whether recurrence is associated with the following additional risk factors for HDP: maternal age, smoking, inter-delivery interval, diabetes, body mass index, and fetal growth restriction, and to assess temporal trends in these associations.
MATERIAL AND METHODS: All women with two singleton births in the Medical Birth Registry of Norway 1967-2012 (n = 742 980) were included in this population-based cohort study. Logistic regression was used to calculate odds ratios for the risk of recurrent HDP according to type of HDP.
RESULTS: The highest odds ratio of recurrence was observed for the same type of HDP based on gestational age at delivery. After gestational hypertension and term preeclampsia, the risk for the same type to recur increased 10-fold, whereas after late and early preterm preeclampsia, the risk increased 27- and 97-fold, respectively. The recurrence of early preterm preeclampsia was less influenced by additional risk factors compared with term HDP. Recurrence of early preterm HDP was significantly lower from 1993 onwards.
CONCLUSIONS: Recurrent HDP tended to be of the same type as the previous HDP. Risk of recurrence associated with additional risk factors was observed particularly after term. The odds ratio of recurrence of early preterm HDP was significantly lower from 1993 onwards.
© 2016 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  High-risk pregnancy; gestational hypertension; hypertensive disorders of pregnancy; population study; preeclampsia; preterm birth; recurrence

Mesh:

Year:  2017        PMID: 27874979     DOI: 10.1111/aogs.13066

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  6 in total

1.  Optimal annual body mass index change for preventing spontaneous preterm birth in a subsequent pregnancy.

Authors:  Sho Tano; Tomomi Kotani; Takafumi Ushida; Masato Yoshihara; Kenji Imai; Tomoko Nakano-Kobayashi; Yoshinori Moriyama; Yukako Iitani; Fumie Kinoshita; Shigeru Yoshida; Mamoru Yamashita; Yasuyuki Kishigami; Hidenori Oguchi; Hiroaki Kajiyama
Journal:  Sci Rep       Date:  2022-10-19       Impact factor: 4.996

2.  Improved implementation of aspirin in pregnancy among Dutch gynecologists: Surveys in 2016 and 2021.

Authors:  Jeske Milou Bij de Weg; Laura Visser; Martijn Alexander Oudijk; Johanna Inge Petra de Vries; Christianne Johanna Maria de Groot; Marjon Alina de Boer
Journal:  PLoS One       Date:  2022-06-09       Impact factor: 3.752

3.  Predicting preeclampsia from a history of preterm birth.

Authors:  Svein Rasmussen; Cathrine Ebbing; Lorentz M Irgens
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

4.  Prevalence and risk of pre-eclampsia and gestational hypertension in twin pregnancies: a population-based register study.

Authors:  Katariina Laine; Gulim Murzakanova; Kristina Baker Sole; Aase Devold Pay; Siri Heradstveit; Sari Räisänen
Journal:  BMJ Open       Date:  2019-07-04       Impact factor: 2.692

5.  Annual body mass index gain and risk of hypertensive disorders of pregnancy in a subsequent pregnancy.

Authors:  Sho Tano; Tomomi Kotani; Takafumi Ushida; Masato Yoshihara; Kenji Imai; Tomoko Nakano-Kobayashi; Yoshinori Moriyama; Yukako Iitani; Fumie Kinoshita; Shigeru Yoshida; Mamoru Yamashita; Yasuyuki Kishigami; Hidenori Oguchi; Hiroaki Kajiyama
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.379

6.  Hypertensive pregnancy complications in women with epilepsy and antiepileptic drugs: a population-based cohort study of first pregnancies in Norway.

Authors:  Kim Christian Danielsson; Ingrid Borthen; Nils-Halvdan Morken; Nils Erik Gilhus
Journal:  BMJ Open       Date:  2018-04-24       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.